Despite the recent reported failure of Thrombolysin in a dog model to lyse preformed clots in small vessels, we believe our study in rats suggests that thrombolytic agents may be useful clinically in reversing the no-reflow phenomenon.
|Original language||English (US)|
|Number of pages||3|
|State||Published - 1983|
ASJC Scopus subject areas